NASDAQ: BNR
Burning Rock Biotech Ltd Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their BNR stock forecasts and price targets.

Forecast return on equity

Is BNR forecast to generate an efficient return?

Forecast return on assets

Is BNR forecast to generate an efficient return on assets?

BNR revenue forecast

What is BNR's revenue in the next 1 years based on estimates from 2 analysts?

Avg 1 year Forecast
$1.1B+1,407.77%

BNR vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
BNR$35.75N/AN/A
ACRS$3.87$16.00+313.44%Buy
PRE$19.29$32.00+65.89%Strong Buy
MYGN$5.92$8.00+35.14%Buy
LAB$1.48$1.35-8.78%Hold

Burning Rock Biotech Stock Forecast FAQ

What is BNR's revenue growth forecast for 2026-2026?

(NASDAQ: BNR) Burning Rock Biotech's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Burning Rock Biotech's revenue in 2026 is $75,740,870.

In 2026, BNR is forecast to generate $123,040,755,314 in revenue, with the lowest revenue forecast at $119,377,545,436 and the highest revenue forecast at $127,889,121,329.

If you're new to stock investing, here's how to buy Burning Rock Biotech stock.

What is BNR's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: BNR) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 9.6%.

What is BNR's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: BNR) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.